British drugmaker GSK said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat ...

The sFlt-1/PlGF ratio did not effectively gauge future preeclampsia risk in pregnant patients with SLE and proteinuria.

Drugmaker GSK said on Tuesday that its linerixibat candidate had shown "positive" Phase III results in cholestatic pruritus ...

The GSK share price has been in a strong freefall after peaking at 1,785p in September. Most recently, the GSK stock ...

The London-based pharmaceutical company said that in cholestatic pruritus, also known as relentless itch, in primary biliary cholangitis, an autoimmune disease known as PBC, linerixibat showed a ...

Shares in this FTSE 100 pharma company have plummeted in recent months. And company insiders are betting on a potential ...

In the chip sector, Broadcom (AVGO), Micron (MU), AMD (AMD), and Intel (INTC) traded lower last week. Traders took profits in ...

In the entertainment sector, Disney (DIS) is another winning stock. The firm reported revenue growth of 6.3% Y/Y to $22.57 ...

Findings from a phase 3 trial with Blenrep, Velcade and dexamethasone in relapsed/refractory multiple myeloma will be ...

Promotes Edward Brennan, MD, FACS to Chief Scientific Officer & Head of R&D ProgramTORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased to ...

Punit Goenka steps down as MD of Zee Entertainment Enterprises (ZEEL) to focus on operational responsibilities, continuing as ...

But other analysts see a real threat. While the HHS secretary holds limited direct powers, analysts at Intron Health see ...